Addressing the global threat of antibiotic resistance

News

VenatoRx Pharmaceuticals to Present at the 2018 UBS Global Healthcare Conference
May 17, 2018
VenatoRx Pharmaceuticals Founders Christopher J. Burns, Ph.D., Luigi Xerri, Ph.D. and Daniel C. Pevear, Ph.D. named EY Entrepreneur Of The Year 2018 Finalists in the Greater Philadelphia Area
April 19, 2018
> See all Press Releases

Pipeline

VenatoRx Team